The assay was able to quantify nanogram amounts of 4EBP1 and Akt 1/2/3 in AML cell lines and primary pediatric AML samples and results were quantifiable, consistent and reproducible. This evidence concerns the gene EIF4EBP1 and acute myeloid leukemia.